Meridian Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Meridian Wealth Management's BMY Position: Q2 2026 in Review
Meridian Wealth Management reduced its Bristol-Myers Squibb (BMY) stake by 4.1% in Q2 2026, selling an estimated $129K and leaving 52,891 shares worth $3.05M. The position accounts for 0.09% of the portfolio, ranked #194.
Meridian Wealth Management first reported a position in BMY in Q1 2017 and has held it in 37 quarters since. The position peaked at $6.89M in Q3 2023. 2,517 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Meridian Wealth Management held 52,891 shares of Bristol-Myers Squibb worth $3.05M as of Q2 2026.
- Meridian Wealth Management sold 2,243 Bristol-Myers Squibb shares in Q2 2026, an estimated $129K.
- Bristol-Myers Squibb made up 0.09% of Meridian Wealth Management's portfolio in Q2 2026, its #194 holding.
- Meridian Wealth Management first reported a position in Bristol-Myers Squibb in Q1 2017 and has held it in 37 quarters since.
- Meridian Wealth Management's Bristol-Myers Squibb position peaked at $6.89M in Q3 2023.
- 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Meridian Wealth Management's 13F filing for Q2 2026, filed 5 Aug 2026.